Skip To Content
Click for DHHS Home Page
Click for the SAMHSA Home Page
Click for the OAS Drug Abuse Statistics Home Page
Click for What's New
Click for Recent Reports and HighlightsClick for Information by TopicClick for OAS Data Systems and more PubsClick for Data on Specific Drugs of UseClick for Short Reports and FactsClick for Frequently Asked QuestionsClick for PublicationsClick to send OAS Comments, Questions and RequestsClick for OAS Home PageClick for Substance Abuse and Mental Health Services Administration Home PageClick to Search Our Site

Non-Heroin Opiate Admissions: 2003

 

The DASIS Report:  Non-Heroin Opiate Admissions, 2003

  • HTML format (also has the data table used to construct each figure)

Highlights

  • Opiates were the primary substance of abuse for 324,000 (18%) of the 1.8 million substance abuse treatment admissions reported to SAMHSA's Treatment Episode Data Set (TEDS) in 2003. Of these, 51,000 (3% of all admissions) were for a non-heroin opiate.
  • Non-heroin opiates include methadone, codeine, Dilaudid, morphine, Demerol, opium, oxycodone, and any other drug with morphine-like effects. 
  • Non-heroin opiate admissions (40%) were more likely than heroin admissions (22%) to be entering treatment for the first time.
  • Non-heroin opiate admissions were less likely than heroin admissions to report cocaine as their secondary substance of abuse (17% vs. 50%) and more likely than heroin admissions to report marijuana as their secondary substance of abuse (19% vs. 10%).

Reports on treatment

Reports on opiates

Other drugs

Other topics

Other OAS publications and services

This OAS Short Report, The DASIS Report:  Non-Heroin Opiate Admissions, 2003, is based on the Drug and Alcohol Services Information System (DASIS), the primary source of national data on substance abuse treatment.  DASIS is conducted by the Office of Applied Studies (OAS) in the Substance Abuse and Mental Health Services Administration (SAMHSA).  

This is the page footer.

This page has been accessed 71703 times since 04/14/06.

This page was last updated on April 14, 2006.

SAMHSA, an agency in the Department of Health and Human Services, is the Federal Government's lead agency for improving the quality and availability of substance abuse prevention, addiction treatment, and mental health services in the United States.

Yellow Line

Site Map | Contact Us | Accessibility Privacy PolicyFreedom of Information ActDisclaimer  |  Department of Health and Human ServicesSAMHSAWhite HouseUSA.gov

* Adobe™ PDF and MS Office™ formatted files require software viewer programs to properly read them. Click here to download these FREE programs now

What's New

Highlights Topics Data Drugs Pubs Short Reports Treatment Help Mail OAS